Clinical trial
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
NCT00001350 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Recruiting
Key facts
| NCT number | NCT00001350 |
|---|---|
| Title | Study of Autoimmune Lymphoproliferative Syndrome (ALPS) |
| Official title | Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated With an Expansion of CD4-8-/TCR Alpha/Beta+ T Cells |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Benign Lymphoproliferative Disorder |
| Enrollment | 1,200 |
| Start date | May 13, 1993 |
| First posted | Nov 4, 1999 |
| Last update posted | Jan 13, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: